CD4 and metabolic disease: Late initiation of ART (e.g. in patients with <200 CD4+ T-cells per μL) is associated with persistently elevated levels of insulin, triglyceride, IL-6 and hsCRP even after three years of undetectable plasma viremia demonstrating long term persistence of systemic inflammation and metabolic disorder even in successfully treated patients39.